BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7255543)

  • 1. Calibration of a 238Pu,Be facility for partial-body measurements of organ cadmium.
    Morgan WD; Ellis KJ; Vartsky D; Yasumura S; Cohn SH
    Phys Med Biol; 1981 Jul; 26(4):577-90. PubMed ID: 7255543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A facility for in vivo measurement of kidney and liver cadmium by neutron capture prompt gamma ray analysis.
    Vartsky D; Ellis KJ; Chen NS; Cohn SH
    Phys Med Biol; 1977 Nov; 22(6):1085-96. PubMed ID: 594140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relations between liver cadmium, cumulative exposure, and renal function in cadmium alloy workers.
    Mason HJ; Davison AG; Wright AL; Guthrie CJ; Fayers PM; Venables KM; Smith NJ; Chettle DR; Franklin DM; Scott MC
    Br J Ind Med; 1988 Dec; 45(12):793-802. PubMed ID: 3219304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal dysfunction in cadmium smelters: relation to in-vivo liver and kidney cadmium concentrations.
    Gompertz D; Chettle DR; Fletcher JG; Mason H; Perkins J; Scott MC; Smith NJ; Topping MD; Blindt M
    Lancet; 1983 May; 1(8335):1185-7. PubMed ID: 6133989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An improved in vivo neutron activation system for measuring kidney cadmium.
    Franklin DM; Armstrong R; Chettle DR; Scott MC
    Phys Med Biol; 1990 Oct; 35(10):1397-408. PubMed ID: 2243844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo neutron activation analysis of organ cadmium burdens. Referent levels in liver and kidney and the impact of smoking.
    Franklin DM; Guthrie CJ; Chettle DR; Scott MC; Mason HJ; Davison AG; Newman Taylor AJ
    Biol Trace Elem Res; 1990; 26-27():401-6. PubMed ID: 1704743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 238Pu/Be facility for in vivo cadmium measurements.
    Fedorowicz RP; Chettle DR; Kennett TJ; Prestwich WV; Webber CE
    Basic Life Sci; 1993; 60():323-4. PubMed ID: 8110138
    [No Abstract]   [Full Text] [Related]  

  • 8. Calibration of a cadmium IVNAA system.
    Ralston A; Utteridge T; Paix D; Beddoe A
    Australas Phys Eng Sci Med; 1994 Mar; 17(1):34-42. PubMed ID: 8198507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological monitoring for occupational cadmium exposure: the urinary metallothionein.
    Shaikh ZA; Ellis KJ; Subramanian KS; Greenberg A
    Toxicology; 1990 Jul; 63(1):53-62. PubMed ID: 2382269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo prompt gamma neutron activation analysis of cadmium in the kidney and liver.
    Grinyer J; Byun SH; Chettle DR
    Appl Radiat Isot; 2005 Oct; 63(4):475-9. PubMed ID: 15994089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occupational cadmium exposure and testicular endocrine function.
    Mason HJ
    Hum Exp Toxicol; 1990 Mar; 9(2):91-4. PubMed ID: 2111158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of cadmium in liver and kidney using in vivo techniques.
    Webb MA; Chettle DR; Al-Haddad IK; Downey SP; Harvey TC
    Ann Occup Hyg; 1982; 25(1):33-7. PubMed ID: 7092014
    [No Abstract]   [Full Text] [Related]  

  • 13. Cadmium: in vivo measurement in smokers and nonsmokers.
    Ellis KJ; Vartsky D; Zanzi I; Cohn SH; Yasumura S
    Science; 1979 Jul; 205(4403):323-5. PubMed ID: 377488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo measurements of cadmium and lead in occupationally-exposed workers and an urban population.
    Morgan WD; Ryde SJ; Jones SJ; Wyatt RM; Hainsworth IR; Cobbold SS; Evans CJ; Braithwaite RA
    Biol Trace Elem Res; 1990; 26-27():407-14. PubMed ID: 1704744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An in-vivo study of renal cadmium and hypertension.
    Cummins PE; Dutton J; Evans CJ; Morgan WD; Sivyer A; Elwood PC
    Eur J Clin Invest; 1980 Dec; 10(6):459-61. PubMed ID: 6788563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A transportable system for measurement of kidney cadmium in vivo.
    Al-Haddad IK; Chettle DR; Fletcher JG; Fremlin JH
    Int J Appl Radiat Isot; 1981 Feb; 32(2):109-12. PubMed ID: 7203702
    [No Abstract]   [Full Text] [Related]  

  • 17. Measurement of liver-cadmium concentrations in patients and industrial workers by neutron-activation analysis.
    Harvey TC; Thomas BJ; McLellan JS; Fremlin JH
    Lancet; 1975 Jun; 1(7919):1269-72. PubMed ID: 48898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvements to the in vivo measurement of cadmium in the kidney by neutron activation analysis.
    McNeill FE; Chettle DR
    Appl Radiat Isot; 1998; 49(5-6):699-700. PubMed ID: 9569583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cadmium inhalation exposure estimates: their significance with respect to kidney and liver cadmium burden.
    Ellis KJ; Cohn SH; Smith TJ
    J Toxicol Environ Health; 1985; 15(1):173-87. PubMed ID: 3884826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinical instrument for multi-element in vivo analysis by prompt, delayed and cyclic neutron activation using 252Cf.
    Ryde SJ; Morgan WD; Sivyer A; Evans CJ; Dutton J
    Phys Med Biol; 1987 Oct; 32(10):1257-71. PubMed ID: 3685095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.